363 related articles for article (PubMed ID: 23166824)
1. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels.
Gurski LA; Xu X; Labrada LN; Nguyen NT; Xiao L; van Golen KL; Jia X; Farach-Carson MC
PLoS One; 2012; 7(11):e50075. PubMed ID: 23166824
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
3. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
4. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors.
Rizzardi AE; Vogel RI; Koopmeiners JS; Forster CL; Marston LO; Rosener NK; Akentieva N; Price MA; Metzger GJ; Warlick CA; Henriksen JC; Turley EA; McCarthy JB; Schmechel SC
Cancer; 2014 Jun; 120(12):1800-9. PubMed ID: 24668563
[TBL] [Abstract][Full Text] [Related]
5. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
7. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of RHC-EGFP fusion protein and its application in hyaluronic acid assay.
Duan N; Lv W; Zhu L; Zheng W; Hua Z
Prep Biochem Biotechnol; 2017 Mar; 47(3):261-267. PubMed ID: 27536858
[TBL] [Abstract][Full Text] [Related]
10. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE; He Y; Daughters C; Knutson TP; Henzler CM; Price MA; Shanley R; Witschen P; Tolg C; Kaspar RE; Hallstrom C; Gittsovich L; Sulciner ML; Zhang X; Forster CL; Lange CA; Shats O; Desler M; Cowan KH; Yee D; Schwertfeger KL; Turley EA; McCarthy JB; Nelson AC
J Pathol; 2023 Jul; 260(3):289-303. PubMed ID: 37186300
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.
Savani RC; Cao G; Pooler PM; Zaman A; Zhou Z; DeLisser HM
J Biol Chem; 2001 Sep; 276(39):36770-8. PubMed ID: 11448954
[TBL] [Abstract][Full Text] [Related]
12. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
[TBL] [Abstract][Full Text] [Related]
13. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
15. Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Veiseh M; Kwon DH; Borowsky AD; Tolg C; Leong HS; Lewis JD; Turley EA; Bissell MJ
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):E1731-9. PubMed ID: 24733940
[TBL] [Abstract][Full Text] [Related]
16. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
[TBL] [Abstract][Full Text] [Related]
17. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.
Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN
Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250
[TBL] [Abstract][Full Text] [Related]
18. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.
Park D; Kim Y; Kim H; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Jeon J; Choi C; Kim YM; Jeoung D
Mol Cells; 2012 Jun; 33(6):563-74. PubMed ID: 22610405
[TBL] [Abstract][Full Text] [Related]
20. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.
Shigeishi H; Higashikawa K; Takechi M
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1629-40. PubMed ID: 24676428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]